PRQR
ProQR Therapeutics N.V
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.82
+0.10 ▲ +5.81%
🌙 3월 13일 4:31 PM ET (한국 3/14 05:31)
$1.80
-0.02 ▼ -1.10%
| Index | - | P/E | - | EPS (ttm) | -0.45 | Insider Own | 32.98% | Shs Outstand | 0.10B | Perf Week | 2.25% |
| Market Cap | 0.19B | Forward P/E | - | EPS next Y | -12.09% | Insider Trans | - | Shs Float | 0.07B | Perf Month | 28.17% |
| Enterprise Value | 0.10B | PEG | - | EPS next Q | -0.14 | Inst Own | 36.16% | Short Float | 2.41% | Perf Quarter | -18.39% |
| Income | -0.05B | P/S | 10.71 | EPS this Y | -33.54% | Inst Trans | -0.39% | Short Ratio | 3.91 | Perf Half Y | -16.89% |
| Sales | 0.02B | P/B | 3.23 | EPS next 5Y | 4.9% | ROA | -31.11% | Short Interest | 1.70M | Perf YTD | -9.9% |
| Book/sh | 0.56 | P/C | 1.77 | EPS past 3/5Y | 21.8% 15.68% | ROE | -63.67% | 52W High | -41.29% ($3.10) | Perf Year | 4.6% |
| Cash/sh | 1.03 | P/FCF | - | Sales past 3/5Y | 68.13% - | ROIC | -68.87% | 52W Low | 70.09% ($1.07) | Perf 3Y | -37.88% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -30.17% | Gross Margin | 82.95% | Volatility(W/M) | 7.48% 7.04% | Perf 5Y | -63.31% |
| Dividend TTM | - | EV/Sales | 5.56 | Sales Y/Y TTM | -12.37% | Oper. Margin | -276.57% | ATR (14) | 0.11 | Perf 10Y | -59.19% |
| Dividend Ex-Date | - | Quick Ratio | 3.09 | EPS Q/Q | 1.95% | Profit Margin | -266.13% | RSI (14) | 59.76 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.09 | Sales Q/Q | 18.77% | SMA20 | 12.8% ($1.61) | Beta | 0.07 | Target Price | $8.99 |
| Payout | - | Debt/Eq | 0.28 | Earnings | 3000000 | SMA50 | 9.61% ($1.66) | Rel Volume | 1.2 | Prev Close | $1.72 |
| Employees | - | LT Debt/Eq | 0.19 | EPS/Sales Surpr. | 10.56% -14.36% | SMA200 | -12.04% ($2.07) | Avg Volume(3M) | 0.44M | Price | $1.82 |
| IPO | 2014/9/18 | Option/Short | Yes/Yes | Trades | 1500 | Volume | 524,510 | Change | 5.81% |
뉴스 로딩 중...